Mengze Zhou

State Key Laboratory Of Natural Medicines, Key Laboratory Of Drug Metabolism And Pharmacokinetics, Nanjing 210009, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Erratum: Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis: Erratum.

Erratum: Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis: Erratum.

Journal: International journal of biological sciences

Published: January 09, 2025

Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease.

Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease.

Journal: Journal of ethnopharmacology

Published: June 13, 2023

Discovery of Selective P2Y6R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy.

Discovery of Selective P2Y6R Antagonists with High Affinity and In Vivo Efficacy for Inflammatory Disease Therapy.

Journal: Journal of medicinal chemistry

Published: April 20, 2023

Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease.

Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease.

Journal: International journal of biological macromolecules

Published: November 05, 2022

HQL6 serves as a novel P2Y14 receptor antagonist to ameliorate acute gouty arthritis through inhibiting macrophage pyroptosis.

HQL6 serves as a novel P2Y14 receptor antagonist to ameliorate acute gouty arthritis through inhibiting macrophage pyroptosis.

Journal: International immunopharmacology

Published: October 14, 2022

Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis.

Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis.

Journal: International journal of biological sciences

Published: March 19, 2020

P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages.

P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages.

Journal: Cell death & disease

Published: February 20, 2020

HJ22, a Novel derivative of piperine, Attenuates ibotenic acid-induced cognitive impairment, oxidativestress, apoptosis and inflammation via inhibiting the protein-protein interaction of Keap1-Nrf2.

HJ22, a Novel derivative of piperine, Attenuates ibotenic acid-induced cognitive impairment, oxidativestress, apoptosis and inflammation via inhibiting the protein-protein interaction of Keap1-Nrf2.

Journal: International immunopharmacology

Published: December 03, 2019

Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.

Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.

Journal: Bioorganic & medicinal chemistry letters

Published: November 20, 2019

The role of P2Y6R in cardiovascular diseases and recent development of P2Y6R antagonists.

The role of P2Y6R in cardiovascular diseases and recent development of P2Y6R antagonists.

Journal: Drug discovery today

Published: September 30, 2019

Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout.

Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout.

Journal: Bioorganic & medicinal chemistry

Published: January 24, 2018

Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.

Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 14, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026